None listed
Conditions
Interventions
None listed
Sponsors
National Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 years or older 2. Presence of a pulmonary lesion identified on chest computed tomography (CT), requiring diagnostic biopsy or interventional localization 3. Eastern Cooperative Oncology Group (ECOG) performance status of 0-2, or an equivalent functional status permitting sedation or general anesthesia for the procedure
Exclusion criteria
Exclusion criteria: 1. Any absolute contraindications to bronchoscopy, including: Severe hypoxemia (oxygen saturation < 90%), Severe pulmonary hypertension, Recent myocardial infarction within the past 6 weeks, Unstable angina, Malignant arrhythmias 2. Uncontrolled or irreversible coagulopathy (e.g., platelet count < 50,000/µL) 3. Inability to undergo sedation or general anesthesia due to severe cardiopulmonary dysfunction (e.g., contraindication to general anesthesia) 4. Cervical spine instability 5. Pregnant or breastfeeding women 6. Life expectancy less than 6 months as determined by the attending physician 7. Concurrent participation in another interventional clinical trial that may interfere with the study procedures or outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic performance of ss-RAB;Localization Performance of ss-RAB | — |
Secondary
| Measure | Time frame |
|---|---|
| Subgroup, Predictive Factor, and Treat Impact Analyses of Diagnostic RAB;Subgroup, Predictive Factor, and Clinical Utility Analyses of Localization RAB | — |
Countries
Korea, Republic of
Contacts
Public ContactHye ran Gwon
National Cancer Center
Outcome results
None listed